"EIA receivables rose 62%"
Does anyone want to weigh in
"EIA receivables rose 62%"
Does anyone want to weigh in on this very encouraging tweet from the Muse today? In order for anything to rise 1%, 10% or 62%, there must be a starting point (basis) from which to rise. Could it be the "sugar" EIA deal closed in September so the November receivable discussed in the tweet could be 62% higher than September receivables? Has anyone heard Bill or Muse confirm a closed EIA deal?
****Muse has been making some very specific statements lately. Can't wait to see the K and next Q.**** Even better - an 8k listing specific revenue/deals would make a nice Christmas present.
Your thoughts?
5
Trans-Pacific Aerospace (TPAC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the rough-and-tumble world of mobile advertising, cutting through the noise with real results is no easy feat. Yet Bidease finds itself riding high on a wave of growth—200% revenue increase over back-to-back years. That's no small potatoes, and now they're topping it off with a savvy hire: Dock Kim, the former revenue honcho at Moloco, is on deck as the new VP of...
Continue Reading
Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...
Continue Reading
Bybit Extends USD1 Hold & Earn Program Man, when it comes to dangling a carrot, Bybit seems to know just the right length of stick to use. For those riding the crypto wave, they're reevaluating the worth of holding onto their digital coins, especially now that Bybit has renewed its USD1 Hold & Earn program. This isn't just a token gesture—it's a whopping 27 million WLFI...
Continue Reading
Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...
Continue Reading
Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...
Continue Reading
A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...
Continue Reading
Preparing for the Real Estate Rollercoaster Getting ready to sell your home? Let's cut through the noise and get right into the nitty-gritty with Jodi Kallus, a seasoned real estate pro with Summit Realtors. The first step ain't just about slapping a ‘For Sale’ sign on your front lawn. It's about laying down a plan that's as solid as the foundation of the house you're...
Continue Reading
If you think living in a rural area means settling for second best when it comes to healthcare, Tampa General Hospital's got news for you. A brand-new cancer center is sprouting up in Loxahatchee—aimed squarely at providing top-tier cancer care to Florida's Glades region, where communities often get the short end of the stick when it comes to healthcare access. And...
Continue Reading
An Event Gemmed with Strategic Importance The Middle East is about to see its streets glitter even more than usual. Next week, the Jewellery, Gem & Technology in Dubai (JGTD) event rolls into town, packed with brands that’ll drop in like swanky diamonds. We’re talking 300 heavy-duty exhibitors from all corners of the globe, ready to strut their stuff at the DEC Expo...
Continue Reading
A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...
Continue Reading
Top 5 Most Recently Viewed Articles
Hyzon Receives Order for Hydrogen Fuel Cell Electric Trucks Hyzon, an innovator in hydrogen fuel cell systems, has announced an exciting new order for two Fuel Cell Electric Trucks (FCETs). This marks a significant step for the company as it continues to provide sustainable solutions for refuse collection through advanced technology. The order comes from a reputable...
Continue Reading
Heron Therapeutics Achieves Remarkable Financial Results Heron Therapeutics, Inc. (Nasdaq: HRTX) has announced its outstanding financial performance for 2024, showcasing impressive results that highlight the company's strategic advancements within the biotechnology sector. The company reported a Q4 2024 GAAP net income of $3.6 million, leading to a profitable year-end...
Continue Reading
Imperative Logistics Group Expands with DTH Expeditors Imperative Logistics Group has recently made a strategic move by acquiring DTH Expeditors, Inc., a prominent provider in high-touch domestic expedited services. This acquisition significantly enhances Imperative's capabilities in the next-flight-out (NFO) logistics sector, which is increasingly vital in today’s...
Continue Reading
Understanding Your Rights as a Five Below, Inc. Shareholder As a shareholder, it’s crucial to understand your rights in the corporate landscape. Five Below, Inc. (NASDAQ: FIVE) is a well-known company, and being a shareholder means you have a stake in the success and governance of the organization. If you have been investing in its stocks for a significant period,...
Continue Reading
Jefferies Initiates Coverage on Endesa with a Hold Rating Endesa, S.A. (ELE:SM) (OTC: ELEZY) recently came under the spotlight as Jefferies offered new coverage on the stock, assigning it a Hold rating. The analysts set a price target of EUR21.00, a value derived from the company's financial health and the evolving regulatory landscape in Spain. Jefferies emphasized that...
Continue Reading